Mayo Clinic's blood disorder researchers are actively studying new ways of treating chronic myelogenous leukemia.

Blood cell and bone marrow cancer research is conducted by the Hematologic Malignancies Program in coordination with the Mayo Clinic Cancer Center. The Mayo Clinic Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center — recognition for an institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.


See a list of publications on chronic myelogenous leukemia by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.